Gene-environment interactions in vulnerability to cocaine intravenous self-administration: a brief social experience affects intake in DBA/2J but not in C57BL/6J mice.
Identifieur interne : 001B39 ( Main/Corpus ); précédent : 001B38; suivant : 001B40Gene-environment interactions in vulnerability to cocaine intravenous self-administration: a brief social experience affects intake in DBA/2J but not in C57BL/6J mice.
Auteurs : Rixt Van Der Veen ; Pier Vincenzo Piazza ; Véronique Deroche-GamonetSource :
- Psychopharmacology [ 0033-3158 ] ; 2007.
English descriptors
- KwdEn :
- Analysis of Variance (MeSH), Animals (MeSH), Brain (metabolism), Cocaine (administration & dosage), Cocaine (metabolism), Cocaine (pharmacology), Cocaine-Related Disorders (genetics), Cocaine-Related Disorders (psychology), Dose-Response Relationship, Drug (MeSH), Environment (MeSH), Housing, Animal (MeSH), Injections, Intravenous (MeSH), Mice (MeSH), Mice, Inbred C57BL (MeSH), Mice, Inbred DBA (MeSH), Narcotics (metabolism), Narcotics (pharmacology), Phenotype (MeSH), Self Administration (MeSH), Social Isolation (MeSH), Species Specificity (MeSH).
- MESH :
- chemical , administration & dosage : Cocaine.
- genetics : Cocaine-Related Disorders.
- metabolism : Brain, Cocaine, Narcotics.
- chemical , pharmacology : Cocaine, Narcotics.
- psychology : Cocaine-Related Disorders.
- Analysis of Variance, Animals, Dose-Response Relationship, Drug, Environment, Housing, Animal, Injections, Intravenous, Mice, Mice, Inbred C57BL, Mice, Inbred DBA, Phenotype, Self Administration, Social Isolation, Species Specificity.
Abstract
RATIONALE
Individual differences in cocaine-taking behavior and liability to develop abuse are clearly observed, but underlying mechanisms are still poorly understood. A role for gene-environment interactions has been proposed but remains hypothetical.
OBJECTIVES
We investigated whether gene-environment interactions influence intravenous cocaine self-administration (SA) in mice. We tested the effect of a past short group housing experience on cocaine SA in two inbred strains of mice, the C57BL/6J (C57) and DBA/2J (DBA).
METHODS
Adult C57 and DBA mice were individually housed upon arrival in the laboratory. After 3 weeks, half of the animals of each strain were group housed for 19 days. One week after the end of group housing, cocaine SA or measurement of brain cocaine levels took place.
RESULTS
Individually and ex-group-housed C57 mice did not differ for cocaine SA. On the contrary, the ex-group-housed DBA mice showed an upward shift in the dose-response curve as compared to individually housed DBA. Differences in brain cocaine levels could not account for the observed behavioral differences.
CONCLUSIONS
These results demonstrate that vulnerability to cocaine reinforcing effects can be affected by gene-environment interactions. We propose a mouse model for the characterization of gene-environment interactions in the vulnerability to cocaine-taking behavior.
DOI: 10.1007/s00213-007-0777-0
PubMed: 17396246
Links to Exploration step
pubmed:17396246Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gene-environment interactions in vulnerability to cocaine intravenous self-administration: a brief social experience affects intake in DBA/2J but not in C57BL/6J mice.</title><author><name sortKey="Van Der Veen, Rixt" sort="Van Der Veen, Rixt" uniqKey="Van Der Veen R" first="Rixt" last="Van Der Veen">Rixt Van Der Veen</name><affiliation><nlm:affiliation>Centre de recherche INSERM U862 Physiopathologie de la plasticité neuronale, Institut François Magendie, Université de Bordeaux 2, 146 rue Léo Saignat, 33077 Bordeaux Cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Piazza, Pier Vincenzo" sort="Piazza, Pier Vincenzo" uniqKey="Piazza P" first="Pier Vincenzo" last="Piazza">Pier Vincenzo Piazza</name></author><author><name sortKey="Deroche Gamonet, Veronique" sort="Deroche Gamonet, Veronique" uniqKey="Deroche Gamonet V" first="Véronique" last="Deroche-Gamonet">Véronique Deroche-Gamonet</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17396246</idno><idno type="pmid">17396246</idno><idno type="doi">10.1007/s00213-007-0777-0</idno><idno type="wicri:Area/Main/Corpus">001B39</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001B39</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Gene-environment interactions in vulnerability to cocaine intravenous self-administration: a brief social experience affects intake in DBA/2J but not in C57BL/6J mice.</title><author><name sortKey="Van Der Veen, Rixt" sort="Van Der Veen, Rixt" uniqKey="Van Der Veen R" first="Rixt" last="Van Der Veen">Rixt Van Der Veen</name><affiliation><nlm:affiliation>Centre de recherche INSERM U862 Physiopathologie de la plasticité neuronale, Institut François Magendie, Université de Bordeaux 2, 146 rue Léo Saignat, 33077 Bordeaux Cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Piazza, Pier Vincenzo" sort="Piazza, Pier Vincenzo" uniqKey="Piazza P" first="Pier Vincenzo" last="Piazza">Pier Vincenzo Piazza</name></author><author><name sortKey="Deroche Gamonet, Veronique" sort="Deroche Gamonet, Veronique" uniqKey="Deroche Gamonet V" first="Véronique" last="Deroche-Gamonet">Véronique Deroche-Gamonet</name></author></analytic><series><title level="j">Psychopharmacology</title><idno type="ISSN">0033-3158</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Analysis of Variance (MeSH)</term><term>Animals (MeSH)</term><term>Brain (metabolism)</term><term>Cocaine (administration & dosage)</term><term>Cocaine (metabolism)</term><term>Cocaine (pharmacology)</term><term>Cocaine-Related Disorders (genetics)</term><term>Cocaine-Related Disorders (psychology)</term><term>Dose-Response Relationship, Drug (MeSH)</term><term>Environment (MeSH)</term><term>Housing, Animal (MeSH)</term><term>Injections, Intravenous (MeSH)</term><term>Mice (MeSH)</term><term>Mice, Inbred C57BL (MeSH)</term><term>Mice, Inbred DBA (MeSH)</term><term>Narcotics (metabolism)</term><term>Narcotics (pharmacology)</term><term>Phenotype (MeSH)</term><term>Self Administration (MeSH)</term><term>Social Isolation (MeSH)</term><term>Species Specificity (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cocaine</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Cocaine-Related Disorders</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Brain</term><term>Cocaine</term><term>Narcotics</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Cocaine</term><term>Narcotics</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Cocaine-Related Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Analysis of Variance</term><term>Animals</term><term>Dose-Response Relationship, Drug</term><term>Environment</term><term>Housing, Animal</term><term>Injections, Intravenous</term><term>Mice</term><term>Mice, Inbred C57BL</term><term>Mice, Inbred DBA</term><term>Phenotype</term><term>Self Administration</term><term>Social Isolation</term><term>Species Specificity</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>RATIONALE</b></p><p>Individual differences in cocaine-taking behavior and liability to develop abuse are clearly observed, but underlying mechanisms are still poorly understood. A role for gene-environment interactions has been proposed but remains hypothetical.</p></div><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b></p><p>We investigated whether gene-environment interactions influence intravenous cocaine self-administration (SA) in mice. We tested the effect of a past short group housing experience on cocaine SA in two inbred strains of mice, the C57BL/6J (C57) and DBA/2J (DBA).</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Adult C57 and DBA mice were individually housed upon arrival in the laboratory. After 3 weeks, half of the animals of each strain were group housed for 19 days. One week after the end of group housing, cocaine SA or measurement of brain cocaine levels took place.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Individually and ex-group-housed C57 mice did not differ for cocaine SA. On the contrary, the ex-group-housed DBA mice showed an upward shift in the dose-response curve as compared to individually housed DBA. Differences in brain cocaine levels could not account for the observed behavioral differences.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>These results demonstrate that vulnerability to cocaine reinforcing effects can be affected by gene-environment interactions. We propose a mouse model for the characterization of gene-environment interactions in the vulnerability to cocaine-taking behavior.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17396246</PMID><DateCompleted><Year>2007</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0033-3158</ISSN><JournalIssue CitedMedium="Print"><Volume>193</Volume><Issue>2</Issue><PubDate><Year>2007</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Psychopharmacology</Title><ISOAbbreviation>Psychopharmacology (Berl)</ISOAbbreviation></Journal><ArticleTitle>Gene-environment interactions in vulnerability to cocaine intravenous self-administration: a brief social experience affects intake in DBA/2J but not in C57BL/6J mice.</ArticleTitle><Pagination><MedlinePgn>179-86</MedlinePgn></Pagination><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Individual differences in cocaine-taking behavior and liability to develop abuse are clearly observed, but underlying mechanisms are still poorly understood. A role for gene-environment interactions has been proposed but remains hypothetical.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We investigated whether gene-environment interactions influence intravenous cocaine self-administration (SA) in mice. We tested the effect of a past short group housing experience on cocaine SA in two inbred strains of mice, the C57BL/6J (C57) and DBA/2J (DBA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Adult C57 and DBA mice were individually housed upon arrival in the laboratory. After 3 weeks, half of the animals of each strain were group housed for 19 days. One week after the end of group housing, cocaine SA or measurement of brain cocaine levels took place.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Individually and ex-group-housed C57 mice did not differ for cocaine SA. On the contrary, the ex-group-housed DBA mice showed an upward shift in the dose-response curve as compared to individually housed DBA. Differences in brain cocaine levels could not account for the observed behavioral differences.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results demonstrate that vulnerability to cocaine reinforcing effects can be affected by gene-environment interactions. We propose a mouse model for the characterization of gene-environment interactions in the vulnerability to cocaine-taking behavior.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Veen</LastName><ForeName>Rixt</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre de recherche INSERM U862 Physiopathologie de la plasticité neuronale, Institut François Magendie, Université de Bordeaux 2, 146 rue Léo Saignat, 33077 Bordeaux Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piazza</LastName><ForeName>Pier Vincenzo</ForeName><Initials>PV</Initials></Author><Author ValidYN="Y"><LastName>Deroche-Gamonet</LastName><ForeName>Véronique</ForeName><Initials>V</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Psychopharmacology (Berl)</MedlineTA><NlmUniqueID>7608025</NlmUniqueID><ISSNLinking>0033-3158</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009294">Narcotics</NameOfSubstance></Chemical><Chemical><RegistryNumber>I5Y540LHVR</RegistryNumber><NameOfSubstance UI="D003042">Cocaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003042" MajorTopicYN="N">Cocaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019970" MajorTopicYN="N">Cocaine-Related Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004777" MajorTopicYN="N">Environment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006799" MajorTopicYN="Y">Housing, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008811" MajorTopicYN="N">Mice, Inbred DBA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009294" MajorTopicYN="N">Narcotics</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012646" MajorTopicYN="N">Self Administration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012934" MajorTopicYN="N">Social Isolation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>03</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>3</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>9</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>3</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17396246</ArticleId><ArticleId IdType="doi">10.1007/s00213-007-0777-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Synapse. 2005 Dec 1;58(3):211-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16138319</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Neurosci. 1988 Dec;102(6):894-905</Citation><ArticleIdList><ArticleId IdType="pubmed">3214540</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2004 Mar;184:216-22</Citation><ArticleIdList><ArticleId IdType="pubmed">14990519</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2001 Aug;179:116-21</Citation><ArticleIdList><ArticleId IdType="pubmed">11483472</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Jul 18;301(5631):386-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12869766</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2003 Aug;27(5):457-91</Citation><ArticleIdList><ArticleId IdType="pubmed">14505687</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 2005 Dec 30;68(3):171-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16325017</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1998 Jul;138(1):82-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9694530</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neurobiol. 1997 Apr;51(6):637-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9175160</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 1991 Jan;38(1):69-75</Citation><ArticleIdList><ArticleId IdType="pubmed">2017456</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2004 Jan;29(1):72-80</Citation><ArticleIdList><ArticleId IdType="pubmed">12968132</ArticleId></ArticleIdList></Reference><Reference><Citation>Synapse. 2005 Apr;56(1):29-38</Citation><ArticleIdList><ArticleId IdType="pubmed">15700287</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1997 Jul;132(2):107-24</Citation><ArticleIdList><ArticleId IdType="pubmed">9266608</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Psychopathol. 2005 Winter;17(1):67-84</Citation><ArticleIdList><ArticleId IdType="pubmed">15971760</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 1997 Jun;281(3):1392-400</Citation><ArticleIdList><ArticleId IdType="pubmed">9190875</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2007 Feb 27;177(2):290-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17174413</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Pharmacol Sci. 2003 Nov;24(11):566-73</Citation><ArticleIdList><ArticleId IdType="pubmed">14607079</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcohol. 1999 Jun-Jul;18(2-3):177-87</Citation><ArticleIdList><ArticleId IdType="pubmed">10456570</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Rev. 2001 Jun;53(2):209-43</Citation><ArticleIdList><ArticleId IdType="pubmed">11356984</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2002 Aug 2;297(5582):851-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12161658</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Pharmacol Toxicol. 1996;36:359-78</Citation><ArticleIdList><ArticleId IdType="pubmed">8725394</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Res. 2006 Jul;55(3):244-54</Citation><ArticleIdList><ArticleId IdType="pubmed">16644048</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2002 Feb 1;129(1-2):179-85</Citation><ArticleIdList><ArticleId IdType="pubmed">11809509</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2007 Feb 27;177(2):329-39</Citation><ArticleIdList><ArticleId IdType="pubmed">17150264</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 1990 Nov 19;533(2):353-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2289151</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1185-91</Citation><ArticleIdList><ArticleId IdType="pubmed">12452544</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 1994 Jun;48(2):327-35</Citation><ArticleIdList><ArticleId IdType="pubmed">8090798</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Behav. 1997 Apr;61(4):499-506</Citation><ArticleIdList><ArticleId IdType="pubmed">9108567</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2006 Jul;7(7):583-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16791147</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Res. 2006 May;55(1):96-104</Citation><ArticleIdList><ArticleId IdType="pubmed">16580757</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2006 Mar;1(1):5-27</Citation><ArticleIdList><ArticleId IdType="pubmed">26151183</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 1999 Apr 23;265(3):151-4</Citation><ArticleIdList><ArticleId IdType="pubmed">10327153</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2002 Mar 10;130(1-2):103-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11864725</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2000 Jul 21;289(5478):463-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10903209</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2003 Jun 1;23(11):4785-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12805318</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Neurosci. 2002 Aug;16(3):387-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12193179</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 1997 Jul;57(3):429-40</Citation><ArticleIdList><ArticleId IdType="pubmed">9218267</ArticleId></ArticleIdList></Reference><Reference><Citation>Addict Biol. 2004 Sep-Dec;9(3-4):265-71</Citation><ArticleIdList><ArticleId IdType="pubmed">15511722</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1999 Jun 4;284(5420):1670-2</Citation><ArticleIdList><ArticleId IdType="pubmed">10356397</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscience. 2006 Nov 17;143(1):141-53</Citation><ArticleIdList><ArticleId IdType="pubmed">16938406</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 1997 Jul;57(3):487-93</Citation><ArticleIdList><ArticleId IdType="pubmed">9218273</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Behav. 1990 Apr;47(4):749-53</Citation><ArticleIdList><ArticleId IdType="pubmed">2385649</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Pharmacol Sci. 2005 Aug;26(8):420-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15992935</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2002 Nov;164(2):138-43</Citation><ArticleIdList><ArticleId IdType="pubmed">12404075</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 1990 Jul;36(3):515-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2377652</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 2006 Aug;318(2):629-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16651400</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2003 Dec;17(6):426-37</Citation><ArticleIdList><ArticleId IdType="pubmed">14583234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2004 Jun;1018:192-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15240368</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neurobiol Exp (Wars). 2005;65(1):29-38</Citation><ArticleIdList><ArticleId IdType="pubmed">15794029</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2004 Nov 5;155(1):135-46</Citation><ArticleIdList><ArticleId IdType="pubmed">15325787</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2006 Oct;99(1):308-20</Citation><ArticleIdList><ArticleId IdType="pubmed">16987253</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1995 Dec;122(3):281-91</Citation><ArticleIdList><ArticleId IdType="pubmed">8748397</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1995 Nov;52(11):916-24</Citation><ArticleIdList><ArticleId IdType="pubmed">7487340</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):13-33</Citation><ArticleIdList><ArticleId IdType="pubmed">11750768</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2004 Jul 9;305(5681):217</Citation><ArticleIdList><ArticleId IdType="pubmed">15247473</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2005 Apr;48(5):685-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15814103</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 1998 Jul;23(5):505-17</Citation><ArticleIdList><ArticleId IdType="pubmed">9802125</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 1992 Sep;43(1):53-60</Citation><ArticleIdList><ArticleId IdType="pubmed">1409819</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscience. 2006 Aug 25;141(2):597-605</Citation><ArticleIdList><ArticleId IdType="pubmed">16713106</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurobiol. 2003 Jan;54(1):283-311</Citation><ArticleIdList><ArticleId IdType="pubmed">12486710</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2005 May 15;57(10):1117-27</Citation><ArticleIdList><ArticleId IdType="pubmed">15866551</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2006;30(2):215-38</Citation><ArticleIdList><ArticleId IdType="pubmed">16099045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B39 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001B39 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:17396246
|texte= Gene-environment interactions in vulnerability to cocaine intravenous self-administration: a brief social experience affects intake in DBA/2J but not in C57BL/6J mice.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:17396246" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |